id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-6702-0022,FDA,FDA-2017-D-6702,"The Least Burdensome Provisions: Concept and Principles; Guidance for
Industry and Food and Drug Administration Staff; Availability",Notice,Notice of Availability,2019-02-05T05:00:00Z,2019,2,2019-02-05T05:00:00Z,,2019-02-05T14:28:20Z,2019-01022,0,0,0900006483a3ea3d
FDA-2017-D-6702-0023,FDA,FDA-2017-D-6702,The Least Burdensome Provisions: Concept and Principles; Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2019-02-05T05:00:00Z,2019,2,2019-02-05T05:00:00Z,,2024-11-12T22:54:49Z,,1,0,0900006483a3eebd
FDA-2017-D-6702-0021,FDA,FDA-2017-D-6702,The Least Burdensome Provisions: Concept and Principles; Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2019-02-04T05:00:00Z,2019,2,2019-02-04T05:00:00Z,,2020-04-21T18:54:25Z,,0,0,0900006483a38cf1
FDA-2017-D-6702-0007,FDA,FDA-2017-D-6702,The Least Burdensome Provisions: Concept and Principles; Draft Guidance for Industry and Food and Drug Administration Staff; Availability; Extension of Comment Period,Notice,Extension of Comment Period,2018-01-23T05:00:00Z,2018,1,2018-01-23T05:00:00Z,2018-03-16T03:59:59Z,2018-03-16T01:02:19Z,2018-01122,0,0,0900006482e4a73a
FDA-2017-D-6702-0005,FDA,FDA-2017-D-6702,Request for Extension from Advanced Medical Technology Association (AdvaMed),Other,Request for Extension,2017-12-20T05:00:00Z,2017,12,2017-12-20T05:00:00Z,,2017-12-20T21:55:56Z,,0,0,0900006482d3cc99
FDA-2017-D-6702-0004,FDA,FDA-2017-D-6702,Request for Extension from Advanced Medical Technology Association (AdvaMed),Other,Request for Extension,2017-12-20T05:00:00Z,2017,12,2017-12-20T05:00:00Z,,2017-12-20T21:54:30Z,,0,0,0900006482d3cc75
FDA-2017-D-6702-0001,FDA,FDA-2017-D-6702,The Least Burdensome Provisions: Concept and Principles; Draft Guidance for Industry and Food and Drug Administration Staff; Availability,Notice,Notice of Availability,2017-12-15T05:00:00Z,2017,12,2017-12-15T05:00:00Z,2018-02-14T04:59:59Z,2018-01-24T02:04:12Z,2017-26987,0,0,0900006482d1290f
FDA-2017-D-6702-0002,FDA,FDA-2017-D-6702,Draft Guidance for Industry The Least Burdensome Provisions Concept and Principles,Other,Guidance,2017-12-15T05:00:00Z,2017,12,2017-12-15T05:00:00Z,,2024-11-07T01:13:13Z,,1,0,0900006482d1482c